MRK

Health Care Sector Update for 03/13/2018: ABBV, BLCM, EPZM, MRK

Top Health-care stocks:

JNJ: +0.3%

PFE: +0.3%

ABT: flat

MRK: flat

AMGN: flat

Health care shares were mostly higher ahead of the bell on Tuesday.

Expected movers:

- Bellicum Pharma ( BLCM ): reports low rates of cancer recurrence in AML patients treated with BPX-501

- AbbVie ( ABBV ): phase 3 study of Elagolix in women with uterine fibroids meets primary endpoint

- Epizyme ( EPZM ): reports narrower-than-expected Q4 loss

Other news:

- Merck ( MRK ): US FDA grants priority review for Keytruda as cervical cancer treatment

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.